Newsroom

For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

Brain image and venogram.
New MS imaging recommendations from international cooperative on MRI Nov 21, 2016

In order to effectively use brain imaging to diagnose diseases, physicians and other healthcare professionals need to know what they are looking at. New guidelines co-authored by MRI scientist and physicist Dr. Alex Rauscher, published recently in Nature Reviews Neurology, may improve the process of diagnosis for multiple sclerosis (MS).

+
Antibiotic restores cell communication in brain areas damaged by Alzheimer's disease Nov 11, 2016

New research from Dr. Brian MacVicar’s lab has found a way to partially restore brain cell communication around areas damaged by plaques associated with Alzheimer’s disease. The findings, published this week in Nature Communications, demonstrate a possible target and a potential drug treatment to reduce damage to the brain that occurs in the early stages of Alzheimer’s disease.

+
Walk10Blocks makes it easier for sedentary adults to get moving Nov 3, 2016

Research shows that walking just ten blocks per day can have neuroprotective benefits as many as nine years later – Walk10Blocks makes it easy to take the first steps toward improved cognition and joint and cardiovascular health

+
Woman plays Parkinson games on iPad.
Cognitive assessment app puts Parkinson disease monitoring in patients’ hands Oct 25, 2016

Diseases of the brain are different from other diseases in that there just isn’t the technology to monitor patients and paint a holistic picture of the way that symptoms differ over the course of a day, a week, or the months between clinic visits the way there is for diseases of the cardiovascular or respiratory systems.

+
Harnessing electricity to treat depression – in a kinder, gentler way Oct 21, 2016

Sean Tajadod sits at a table as two electrodes are strapped to his head, held in place by a cloth cap. The electrodes are attached to a small device the size of a smartphone, powered by nothing more than two AA batteries. When it is turned on, Sean just sits there – no shaking, no loss of consciousness. In six minutes, it’s over.

“I was feeling a tingling sensation where the electrodes are,” Tajadod said. He called the sensation “strange at first, but then I got used to it, and I didn’t feel it anymore.”

+
Dog ready to walk.
To protect your memory, get your walking shoes on Oct 20, 2016

For those with memory problems, regular walking may do some good finds new research from Dr. Teresa Liu-Ambrose.

+
Alexander (Alex) McGirr
Vanier scholar Alex McGirr bridges basic science and mood disorders care Oct 3, 2016

“Working with patients gives research a lot of context,” McGirr says. “I envision my research career as being heavily informed by my clinical work as it will guide my questions.”

+
Unique relationship found between gut microbiota and immune markers in kids with MS Sep 30, 2016

Children with multiple sclerosis (MS) may show a disruption in the balance of bacteria in the gut as early as two years into the disease course, suggests new findings from Dr. Helen Tremlett and Dr. Emmanuelle Waubant (University of California, San Francisco) as part of an ongoing investigation into the link between the gut microbiome and MS.

+
Scientists look to Tunisia to find new target for stopping Parkinson disease Sep 28, 2016

By analyzing the DNA of people in remote Tunisian villages, researchers with the Centre for Applied Neurogenetics at the Djavad Mowafaghian Centre for Brain Health have found a gene that affects the onset of symptoms in a common but inherited form of Parkinson disease – providing a potentially useful target in the search for a better treatment.

+
CANMAT releases new guidelines for clinical care and treatment of depression Sep 19, 2016

New guidelines for clinical care and treatment of depression offer accessible, evidence-based treatment options and recommendations for medical and mental health professionals in Canada. The clinical guidelines, from the Canadian Network for Mood and Anxiety Treatments (CANMAT), present rigorous systematic reviews of the most current peer-reviewed research on depression, and reflect the scientific and clinical expertise of a wide range of Canadian health and research professionals.

+

Pages